Consolidated Balance Sheets - USD ($) $ in Millions	Feb. 28, 2025	Feb. 29, 2024
Current
Cash and cash equivalents (note 4)	$ 266.7	$ 175.1
Short-term Investments	71.1	62.0
Accounts Receivable, after Allowance for Credit Loss, Current	173.7	198.7
Other receivables (note 5)	48.4	21.4
Income taxes receivable	1.6	3.6
Other current assets (note 5)	30.0	35.1
Assets held for sale, current (note 3)	0.0	11.6
Total current assets	591.5	507.5
Restricted cash and cash equivalents (note 4)	13.6	25.4
Long-term investments	58.9	35.7
Other long-term assets (note 4)	76.5	54.8
Operating lease right-of-use assets, net	22.0	31.8
Property, plant and equipment, net (note 5)	13.4	21.2
Intangible assets, net (note 5)	47.3	57.5
Goodwill (note 5)	472.4	474.5
Assets held for sale, non-current (note 3)	0.0	186.6
Total assets	1,295.6	1,395.0
Current
Accounts payable	31.1	16.8
Accrued liabilities (note 5)	126.2	113.7
Income taxes payable (note 6)	25.5	28.4
Deferred revenue, current (note 13)	161.5	148.7
Liabilities held for sale, current (note 3)	0.0	49.3
Total current liabilities	344.3	356.9
Deferred revenue, non-current	5.6	14.6
Operating lease liabilities	28.7	37.8
Other long-term liabilities	1.8	3.2
Long-term notes (note 7)	195.3	194.1
Liabilities held for sale, non-current (note 3)	0.0	13.3
Total liabilities	575.7	619.9
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0.0	0.0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 596,230,655 voting common shares (February 29, 2024 - 589,232,539)	2,976.4	2,947.7
Deficit	(2,237.3)	(2,158.3)
Accumulated other comprehensive income (loss)	(19.2)	(14.3)
Total shareholders' equity	719.9	775.1
Total liabilities and shareholders' equity	$ 1,295.6	$ 1,395.0